StockData
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31

ONCOLYTICS BIOTECH INC

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Aug 12, 2026
$0.50−0.00 (-0.36%)

Close on Oct 19, 2026

ONCOLYTICS BIOTECH INC revenue by segment

No segment breakdown reported

Oncolytics Biotech does not break out revenue by segment, region or product in the tagged data of its filings for this period type.